buthionine sulfoximine has been researched along with Cancer of Cervix in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elhammali, AE; Floberg, JM; Huang, X; McCormick, ML; Patti, GJ; Rashmi, R; Schwarz, JK; Spitz, DR | 1 |
| Huang, W; Liu, J; Pang, Y; Yan, D; Zhou, Y; Zhu, X; Zhu, Z | 1 |
| Burger, RA; Fruehauf, JP; Monk, BJ; Parker, R; Radany, EH; Redpath, L | 1 |
| Osmak, M | 1 |
| Dimitriadis, KA; Geromichalos, GD; Kortsaris, AH; Kouretas, D; Papazisis, KT; Sivridis, E; Tsekreli, OK | 1 |
| Hedley, DW; Nicklee, T; Vukovic, V | 1 |
6 other study(ies) available for buthionine sulfoximine and Cancer of Cervix
| Article | Year |
|---|---|
Radioresistant Cervical Cancers Are Sensitive to Inhibition of Glycolysis and Redox Metabolism.
Topics: Animals; Auranofin; Buthionine Sulfoximine; Cell Death; Cell Line, Tumor; Citric Acid Cycle; Deoxyglucose; Female; Glutathione; Glycolysis; Humans; Lactic Acid; Mice, Nude; Oxidation-Reduction; Radiation Tolerance; Reactive Oxygen Species; Thioredoxins; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2018 |
Redox-responsive polyphosphate nanosized assemblies: a smart drug delivery platform for cancer therapy.
Topics: Animals; Antimetabolites; Buthionine Sulfoximine; Cell Survival; Doxorubicin; Drug Carriers; Drug Delivery Systems; Female; Flow Cytometry; Glutathione; HeLa Cells; Humans; Magnetic Resonance Spectroscopy; Mice; Micelles; Nanoparticles; NIH 3T3 Cells; Oxidation-Reduction; Polyphosphates; Surface-Active Agents; Uterine Cervical Neoplasms | 2011 |
Development of an in vitro chemo-radiation response assay for cervical carcinoma.
Topics: Antineoplastic Agents; Buthionine Sulfoximine; Carcinoma, Squamous Cell; Carmustine; Cell Division; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Radiation; Drug Screening Assays, Antitumor; Female; Humans; Paclitaxel; Pilot Projects; Radiation Tolerance; Radiation-Sensitizing Agents; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2002 |
Multifactorial molecular mechanisms are involved in resistance of preirradiated human cervix carcinoma cells to cis-dichlorodiammineplatinum (II) and vincristine.
Topics: Antimetabolites, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Buthionine Sulfoximine; Cadmium; Cadmium Chloride; Carrier Proteins; Chlorides; Cisplatin; Dose-Response Relationship, Drug; Drug Resistance; Ethacrynic Acid; Female; Gamma Rays; Glutathione; Glutathione Transferase; HeLa Cells; Humans; Membrane Glycoproteins; Metallothionein; Methionine Sulfoximine; Ultraviolet Rays; Uterine Cervical Neoplasms; Verapamil; Vincristine | 1993 |
Effects of melatonin on proliferation of cancer cell lines.
Topics: Breast Neoplasms; Buthionine Sulfoximine; Cell Division; Cell Survival; Colonic Neoplasms; DNA Replication; DNA, Neoplasm; Dose-Response Relationship, Drug; Ethacrynic Acid; Female; Glutathione; Humans; Melatonin; Ovarian Neoplasms; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 1998 |
Differential effects of buthionine sulphoximine in hypoxic and non-hypoxic regions of human cervical carcinoma xenografts.
Topics: Animals; Antineoplastic Agents; Buthionine Sulfoximine; Cell Hypoxia; Chromatography, High Pressure Liquid; Etanidazole; Female; Glutathione; Humans; Hydrocarbons, Fluorinated; Image Enhancement; Mice; Mice, SCID; Radiation Tolerance; Tumor Cells, Cultured; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2001 |